Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingra Vollert

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|June 1, 2015
Human engineered heart tissue as a model system for drug testingAlexandra Eder, Ingra Vollert, Arne Hansen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 15, 2012
Physiological aspects of cardiac tissue engineeringThomas Eschenhagen, Alexandra Eder, Ingra Vollert, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 30, 2014
Generation of strip-format fibrin-based engineered heart tissue (EHT)Sebastian Schaaf, Alexandra Eder, Ingra Vollert, et al.
Tissue Engineering. Part A|October 26, 2013
In vitro perfusion of engineered heart tissue through endothelialized channelsIngra Vollert, Moritz Seiffert, Johanna Bachmair, et al.
Basic Research in Cardiology|October 27, 2012
Increased afterload induces pathological cardiac hypertrophy: a new in vitro modelMarc N Hirt, Nils A Sörensen, Lena M Bartholdt, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 4, 2014
Automated analysis of contractile force and Ca2+ transients in engineered heart tissueAndrea Stoehr, Christiane Neuber, Christina Baldauf, et al.
Human Molecular Genetics|April 24, 2012
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathyFelix W Friedrich, Brendan R Wilding, Silke Reischmann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|June 1, 2015
Human engineered heart tissue as a model system for drug testingAlexandra Eder, Ingra Vollert, Arne Hansen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 15, 2012
Physiological aspects of cardiac tissue engineeringThomas Eschenhagen, Alexandra Eder, Ingra Vollert, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 30, 2014
Generation of strip-format fibrin-based engineered heart tissue (EHT)Sebastian Schaaf, Alexandra Eder, Ingra Vollert, et al.
Tissue Engineering. Part A|October 26, 2013
In vitro perfusion of engineered heart tissue through endothelialized channelsIngra Vollert, Moritz Seiffert, Johanna Bachmair, et al.
Basic Research in Cardiology|October 27, 2012
Increased afterload induces pathological cardiac hypertrophy: a new in vitro modelMarc N Hirt, Nils A Sörensen, Lena M Bartholdt, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 4, 2014
Automated analysis of contractile force and Ca2+ transients in engineered heart tissueAndrea Stoehr, Christiane Neuber, Christina Baldauf, et al.
Human Molecular Genetics|April 24, 2012
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathyFelix W Friedrich, Brendan R Wilding, Silke Reischmann, et al.
Pageof 1